Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD)

CUSIP: 67577R102

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
71,813,353
Total 13F shares
3,675,838
Share change
+218,761
Total reported value
$15,952,413
Put/Call ratio
3%
Price per share
$4.34
Number of holders
49
Value change
+$1,001,477
Number of buys
31
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 67577R102?
CUSIP 67577R102 identifies IRD - Opus Genetics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of IRD - Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
1.2%
846,702
$3,175,133 31 Mar 2023
13F
RICE HALL JAMES & ASSOCIATES, LLC
13F
Company
1.1%
809,117
$3,034,189 31 Mar 2023
13F
MAI Capital Management
13F
Company
0.69%
494,690
$1,855,088 31 Mar 2023
13F
Richmond Brothers, Inc.
13F
Company
0.47%
340,526
$1,276,976 31 Mar 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.26%
189,969
$712,000 31 Mar 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.25%
181,370
$680,137 31 Mar 2023
13F
Knoll Capital Management, LLC
13F
Company
0.14%
100,000
$375,000 31 Mar 2023
13F
STATE STREET CORP
13F
Company
0.09%
62,173
$233,149 31 Mar 2023
13F
Diametric Capital, LP
13F
Company
0.08%
55,648
$208,680 31 Mar 2023
13F
BlackRock Finance, Inc.
13F
Company
0.07%
52,201
$195,754 31 Mar 2023
13F
Mina Sooch
3/4/5
President and CEO, Director
class O/S missing
50,000
$163,250 10 Jan 2023
NORTHERN TRUST CORP
13F
Company
0.04%
32,070
$120,263 31 Mar 2023
13F
MORGAN STANLEY
13F
Company
0.04%
28,614
$107,303 31 Mar 2023
13F
TRUST CO OF TOLEDO NA /OH/
13F
Company
0.04%
26,000
$97,500 31 Mar 2023
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.04%
25,592
$95,971 31 Mar 2023
13F
Private Advisor Group, LLC
13F
Company
0.03%
20,000
$75,000 31 Mar 2023
13F
OCCUDO QUANTITATIVE STRATEGIES LP
13F
Company
0.03%
19,623
$73,586 31 Mar 2023
13F
CAPTRUST FINANCIAL ADVISORS
13F
Company
0.03%
19,501
$73,129 31 Mar 2023
13F
Legato Capital Management LLC
13F
Company
0.02%
16,456
$61,710 31 Mar 2023
13F
Cornerstone Capital, Inc.
13F
Company
0.02%
16,357
$61,339 31 Mar 2023
13F
Bank of New York Mellon Corp
13F
Company
0.02%
16,350
$61,313 31 Mar 2023
13F
Bedel Financial Consulting, Inc.
13F
Company
0.02%
15,000
$56,250 31 Mar 2023
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.02%
14,751
$55,316 31 Mar 2023
13F
SIMPLEX TRADING, LLC
13F
Company
0.02%
13,776
$51,000 31 Mar 2023
13F
Stokes Family Office, LLC
13F
Company
0.02%
12,120
$45,450 31 Mar 2023
13F
UNITED BANK
13F
Company
0.02%
11,800
$44,250 31 Mar 2023
13F
LINCOLN NATIONAL CORP
13F
Company
0.02%
11,600
$43,500 31 Mar 2023
13F
KESTRA PRIVATE WEALTH SERVICES, LLC
13F
Company
0.01%
10,000
$37,500 31 Mar 2023
13F
CITADEL ADVISORS LLC
13F
Company
0.01%
3,946
$14,798 31 Mar 2023
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
2,914
$10,928 31 Mar 2023
13F
NATIONAL BANK OF CANADA /FI/
13F
Company
0%
2,000
$7,500 31 Mar 2023
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
1,721
$6,000 31 Mar 2023
13F
GROUP ONE TRADING LLC
13F
Company
0%
1,451
$5,441 31 Mar 2023
13F
CarsonAllaria Wealth Management, Ltd.
13F
Company
0%
1,000
$3,750 31 Mar 2023
13F
Hartford Financial Management Inc.
13F
Company
0%
1,000
$3,750 31 Mar 2023
13F
UBS Group AG
13F
Company
0%
564
$2,115 31 Mar 2023
13F
Aspire Private Capital, LLC
13F
Company
0%
400
$1,500 31 Mar 2023
13F
ICA Group Wealth Management, LLC
13F
Company
0%
32
$121 31 Mar 2023
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
21
$79 31 Mar 2023
13F
New England Capital Financial Advisors LLC
13F
Company
0%
20
$75 31 Mar 2023
13F
TCI Wealth Advisors, Inc.
13F
Company
0%
2
$8 31 Mar 2023
13F

Institutional Holders of Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) as of Q2 2023

As of 30 Jun 2023, Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,675,838 shares. The largest 10 holders included VANGUARD GROUP INC, RICE HALL JAMES & ASSOCIATES, LLC, MAI Capital Management, Richmond Brothers, Inc., GEODE CAPITAL MANAGEMENT, LLC, Knoll Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., STATE STREET CORP, and Stratos Wealth Partners, LTD.. This page lists 49 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
40
Q2 2023 holders
49
Holder diff
9
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 Value $ Q2 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .